NeuClone Makes Progress On Ustekinumab

Reports Positive Phase I Results; Phase III Trial To Begin In 2021

 
• By David Wallace
  
Clinical Trial
NeuClone is pushing ahead with its clinical trials for ustekinumab • Source: Shutterstock

More from Biosimilars

More from Products